CONMED Corporation vs. ENDRA Life Sciences Inc. Common Stock
CONMED Corporation (CNMD) comes out ahead, leading on 5 of 6 compared factors.
Size & Scale
| CNMD | NDRA | |
|---|---|---|
| Market Cap | $1.38 billion | $8.43 million |
| Revenue (TTM) | $1.37 billion | — |
| Net Income (TTM) | $56.50 million | $-5,916,657 |
CNMD leads on 3 of 3 size & scale factors.
Valuation
| CNMD | NDRA | |
|---|---|---|
| P/E Ratio | 24.94 | — |
| Price / Book | 1.33 | 1.34 |
| Price / Sales | 1.01 | — |
CNMD leads on 1 of 1 valuation factors.
Profitability
| CNMD | NDRA | |
|---|---|---|
| Net Margin | 4.12% | — |
| Return on Equity | 5.43% | -93.77% |
CNMD leads on 1 of 1 profitability factors.
Dividend
| CNMD | NDRA | |
|---|---|---|
| Dividend Yield | 1.73% | — |
| Payout Ratio | 43.24 | — |
CNMD and NDRA split the dividend factors evenly.
Risk & Sentiment
| CNMD | NDRA | |
|---|---|---|
| Short Interest | 2.50% | 0.78% |
NDRA leads on 1 of 1 risk & sentiment factors.
Dig deeper: CNMD overview, CNMD financials, NDRA overview, NDRA financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.